Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission after Eradication of Helicobacter Pylori Infection | Zendy

Mohammed Hasosah | Zendy; Abdullah Baothman | Zendy; Mohamed B. Satti | Zendy; Suzanne Y Kutbi | Zendy; Khaled Alghamdi | Zendy; Kevan Jacobson | Zendy

Open Access

Mucosa-Associated Lymphoid Tissue Lymphoma of the Lacrimal Gland: Sustained Remission after Eradication of Helicobacter Pylori Infection

Author(s) -

Mohammed Hasosah,

Abdullah Baothman,

Mohamed B. Satti,

Suzanne Y Kutbi,

Khaled Alghamdi,

Kevan Jacobson

Publication year - 2011

Publication title -

case reports in gastrointestinal medicine

Language(s) - English

Resource type - Journals

eISSN - 2090-6528

pISSN - 2090-6536

DOI - 10.1155/2011/945752

Subject(s) - malt lymphoma , helicobacter pylori , medicine , lymphoma , lacrimal gland , lymphatic system , pathology , mucosa associated lymphoid tissue , radiation therapy , stomach , gastroenterology , chemotherapy

Mucosa-associated lymphoid tissue (MALT) lymphoma is the third most common non-Hodgkin lymphoma, and it is strongly associated with helicobacter pylori infection of the stomach. MALT lymphoma of the lacrimal gland usually presents as a localized disease process in extranodal tissues. The treatment options of MALT lymphoma of the lacrimal gland chiefly include radiation of the tumor, chemotherapy, surgical removal, or a combination of these strategies. We report a case of localized MALT lymphoma of the lacrimal gland, with prolonged sustained remission after eradication of gastric Helicobacter pylori (H. Pylori) infection. He sustains in remission of lacrimal MALT lymphoma for four years without chemotherapy or radiotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research